These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 17910993)

  • 1. Mechanical stress and formation of protein aggregates in neurodegenerative disorders.
    Hachiya NS; Kozuka Y; Kaneko K
    Med Hypotheses; 2008; 70(5):1034-7. PubMed ID: 17910993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
    Gaggelli E; Kozlowski H; Valensin D; Valensin G
    Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
    [No Abstract]   [Full Text] [Related]  

  • 3. The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions.
    Kaneko K; Hachiya NS
    Med Hypotheses; 2006; 67(1):169-71. PubMed ID: 16516399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E; Crews L; Masliah E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ER stress and neurodegenerative diseases.
    Lindholm D; Wootz H; Korhonen L
    Cell Death Differ; 2006 Mar; 13(3):385-92. PubMed ID: 16397584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for antiapoptotic drug therapy of neurodegenerative diseases.
    Waldmeier PC
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):303-21. PubMed ID: 12657369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sour side of neurodegenerative disorders: the effects of protein glycation.
    Vicente Miranda H; Outeiro TF
    J Pathol; 2010 May; 221(1):13-25. PubMed ID: 20186922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E and neurodegenerative diseases.
    Ricciarelli R; Argellati F; Pronzato MA; Domenicotti C
    Mol Aspects Med; 2007; 28(5-6):591-606. PubMed ID: 17306357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein misfolding in neurodegenerative diseases.
    Agorogiannis EI; Agorogiannis GI; Papadimitriou A; Hadjigeorgiou GM
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):215-24. PubMed ID: 15175075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing therapeutics for the diseases of protein misfolding.
    May BC; Govaerts C; Cohen FE
    Neurology; 2006 Jan; 66(2 Suppl 1):S118-22. PubMed ID: 16432139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs.
    Forman MS; Trojanowski JQ; Lee VM
    Nat Med; 2004 Oct; 10(10):1055-63. PubMed ID: 15459709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes and the environment in neurodegeneration.
    Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
    Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-misfolding diseases and chaperone-based therapeutic approaches.
    Chaudhuri TK; Paul S
    FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and neurotoxicity.
    Sayre LM; Perry G; Smith MA
    Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of disease II: cellular protein quality control.
    Outeiro TF; Tetzlaff J
    Semin Pediatr Neurol; 2007 Mar; 14(1):15-25. PubMed ID: 17331880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of neurodegenerative disorders: how good are they?
    Rachakonda V; Pan TH; LE WD
    Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
    Tenreiro S; Munder MC; Alberti S; Outeiro TF
    J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.